Experimental Hematology and Oncology Impact Factor, Quartile, Indexing, Ranking

Experimental Hematology and Oncology Impact Factor, Indexing, Ranking

Experimental Hematology and Oncology (EHO) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by BioMed Central. and its abbreviation is Exp Hematol Oncol.

The latest Impact Factor of the Experimental Hematology and Oncology for 2024-2025 is 7.3.

The Publicaiton fees (APC) is £2290.00, $2990.00, €2590.00.


Experimental Hematology and Oncology Aim and Scope

Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings. Experimental Hematology & Oncology publishes original work, hypothesis, commentaries and timely reviews. With open access and rapid turnaround time from submission to publication, the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.


Experimental Hematology and Oncology Details


Journal title Experimental Hematology and Oncology (EHO)
Abbreviation Exp Hematol Oncol
Online ISSN 2162-3619
Publisher Name BioMed Central
Editor-in-chief Professor Delong Liu, MD, PhD, New York Medical College, USA
Subject Category Medicine
Access type Logo of open access journals Open Access
Status 🟢 Active

Experimental Hematology and Oncology Metrics and Rankings

In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.

Below are the metrics and rankings for the journal Experimental Hematology and Oncology

Impact Factor 7.3
SJR 1.908
SNIP 1.609
Ranking 1008
CiteScore 9.5
H-Index 35
Quartile Q1
Experimental Hematology and Oncology Impact Factor List

Experimental Hematology and Oncology Review Time

Journal review time is basically how long it takes for experts to read and decide whether an article is good enough to be published in a journal.

Review Time 79 days

Experimental Hematology and Oncology Abstracting and Indexing

Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars

Abstracting and Indexing

Experimental Hematology and Oncology Submission

If you would like to submit a manuscript or visit the journal's website, please click on the link below.

Journal Submission 🔗 Journal Website

F T L W E